Sydney Lupkin
Stories
-
Health
Moderna And Pfizer On Track To Hit Vaccine Production Goals
Pfizer and Moderna each agreed to supply 100 million doses of COVID-19 vaccine to the U.S. by the end of March. With just under three weeks left, both companies have their work cut out for them.
-
Health
FDA Aims To Be 'Nimble' On COVID-19 Vaccine Changes For Variants
The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.
-
Health
Moderna Increases COVID-19 Vaccine Shipments While Pfizer Lags Behind
The two companies producing COVID-19 vaccines for use in the United States will have to raise production to meet contractual goals of 100 million doses each by the end of March.
-
Health
Moderna And Pfizer Need To Nearly Double COVID-19 Vaccine Deliveries To Meet Goals
The two companies making COVID-19 vaccines each promised to deliver 100 million doses to the federal government by the end of March. So far, they appear to be running behind.
-
National
The Nation's Coronavirus Vaccine Rollout Plan Faces Another Obstacle
The COVID-19 vaccine rollout faces another bottleneck: Pfizer and Moderna may be unable to fulfill contractual promises to deliver 100 million doses a piece to the federal government by March 31.
-
National
Federal Deal To Increase Vaccine Production Could Give Some Employees Early Access
A federal manufacturing contract to increase COVID-19 vaccine production has an unusual clause that could move a company's employees and their families to the front of the vaccination line.
-
Health
COVID-19 Supply Deal Lets Vaccine Maker Earmark Doses For Employees And Their Families
Emergent BioSolutions is under contract with Operation Warp Speed to make COVID-19 vaccines, but the terms could allow employees and their families to get vaccinated ahead of schedule.
-
National
U.S. Government To Buy Additional 100 Million Doses Of Pfizer COVID-19 Vaccine
The federal government reaches an agreement with Pfizer to buy an additional 100 million doses of the COVID-19 vaccine. NPR explores what that means for the country's supply in the coming months.
-
Business
Pfizer, BioNTech Reach Deal To Supply U.S. With More Vaccine Doses
The drugmakers will add an additional 100 million COVID-19 vaccine doses to the number that they are already supplying the government. They expect to deliver all the doses by July 31.
-
Health
Pfizer's Coronavirus Vaccine Supply Contract Excludes Many Taxpayer Protections
The $1.95 billion Operation Warp Speed contract excludes government rights to inventions or production know-how developed in the manufacture of the COVID-19 vaccine.